Barangi, V.C. et al. 2024. Design and synthesis of new coumarin-1,2,3-triazole hybrids as new antidiabetic agents: In vitro α-amylase, α-glucosidase inhibition, anti-inflammatory, and docking study. European Journal of Chemistry. 15, 3 (Sep. 2024), 205–219. DOI:https://doi.org/10.5155/eurjchem.15.3.205-219.2541.